Luengo 1994.
Methods | Randomized, open parallel trial Treatment Sample size at entry: SCT 22; Ca 22 Withdrawals: SCT 5; Ca 5 Trial duration: 24 months | |
Participants | Asthma, steroid dependent patients, received steroids for at least 1 year Mean age: 58.9 years Dose prednisone: 10 mg/d Duration steroid treatment: 9.7 years Women/Men: SCT 19/3; Ca 19/3 Prevalent fractures: SCT 4/22; Ca 4/22 Lumbar BMD (% predicted): SCT 88; Ca 91 | |
Interventions | Intranasal calcitonin 200 IU q 2 days versus untreated Both groups received Calcium 1 gm/d |
|
Outcomes | Lunar DPA: lumbar spine, fractures side effects | |
Notes | Quality score = 2 (R 1, B 0, W 1) |